-
1
-
-
0033892116
-
Treatment of patients with recurrent or metastatic squamous cell carcinoma of head and neck: Current status and future directions
-
Khuri FR, Shin DM, Glisson BS, et al. Treatment of patients with recurrent or metastatic squamous cell carcinoma of head and neck: current status and future directions. Semin Oncol 2000;27:25-33.
-
(2000)
Semin. Oncol.
, vol.27
, pp. 25-33
-
-
Khuri, F.R.1
Shin, D.M.2
Glisson, B.S.3
-
2
-
-
0035353075
-
Chemotherapy in the management of squamous-cell carcinoma of the head and neck
-
Lamont EB, Vokes EE. Chemotherapy in the management of squamous-cell carcinoma of the head and neck. Lancet Oncol 2001; 2:261-269.
-
(2001)
Lancet Oncol.
, vol.2
, pp. 261-269
-
-
Lamont, E.B.1
Vokes, E.E.2
-
4
-
-
0031861077
-
Surgical management of local and regional recurrent head and neck squamous cell carcinoma
-
Watson JC, Ridge JA. Surgical management of local and regional recurrent head and neck squamous cell carcinoma. Carr Opin Oncol 1998;10:207--212.
-
(1998)
Curr. Opin. Oncol.
, vol.10
, pp. 207-212
-
-
Watson, J.C.1
Ridge, J.A.2
-
5
-
-
0033494681
-
Concomitant chemotherapy and reirradiation as management for recurrent head and neck
-
Spencer SA, Wheeler RH, Peters GE, et al. Concomitant chemotherapy and reirradiation as management for recurrent head and neck. Am J Clin Oncol 1999;22:1-5.
-
(1999)
Am. J. Clin. Oncol.
, vol.22
, pp. 1-5
-
-
Spencer, S.A.1
Wheeler, R.H.2
Peters, G.E.3
-
7
-
-
0028850259
-
Superselective intraarterial infusion of cisplatin for squamous cell carcinoma of the mouth
-
Korogi Y, Hirai T, Nishimura R, et al. Superselective intraarterial infusion of cisplatin for squamous cell carcinoma of the mouth. Am J Roentgenol 1995;165:1269-1272.
-
(1995)
Am. J. Roentgenol.
, vol.165
, pp. 1269-1272
-
-
Korogi, Y.1
Hirai, T.2
Nishimura, R.3
-
8
-
-
0029565042
-
Superselective cisplatin (CDDP) - Carboplatin (CBDCA) combined infusion for head and neck cancers
-
Imai S, Kajiwara Y, Munemori O, et al. Superselective cisplatin (CDDP) - carboplatin (CBDCA) combined infusion for head and neck cancers. Eur J Radiol 1995;21:94-99.
-
(1995)
Eur. J. Radiol.
, vol.21
, pp. 94-99
-
-
Imai, S.1
Kajiwara, Y.2
Munemori, O.3
-
9
-
-
0026756177
-
Rapid superselective high-dose cisplatin infusion for advanced head and neck malignancies
-
Robbins KT, Storniolo AM, Kerber C, et al. Rapid superselective high-dose cisplatin infusion for advanced head and neck malignancies. Head Neck 1992;14:364-371.
-
(1992)
Head Neck
, vol.14
, pp. 364-371
-
-
Robbins, K.T.1
Storniolo, A.M.2
Kerber, C.3
-
10
-
-
9244261066
-
Docetaxel: An active drug for squamous cell carcinoma of the head and neck
-
Dreyfuss A, Clark J, Norris C, et al. Docetaxel: an active drug for squamous cell carcinoma of the head and neck. J Clin Oncol 1996; 14:1672-1678.
-
(1996)
J. Clin. Oncol.
, vol.14
, pp. 1672-1678
-
-
Dreyfuss, A.1
Clark, J.2
Norris, C.3
-
11
-
-
0032102421
-
Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: An Eastern Cooperative Oncology Group trial (PA390)
-
Forastiere AA, Shank D, Neuberg D, et al. Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neck: an Eastern Cooperative Oncology Group trial (PA390). Cancer 1998;82:2270-2274.
-
(1998)
Cancer
, vol.82
, pp. 2270-2274
-
-
Forastiere, A.A.1
Shank, D.2
Neuberg, D.3
-
12
-
-
0344820767
-
Docetaxel and cisplatin: An active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC Early Clinical Studies Group
-
Schöffski P, Wanders J, Catimel G, et al. Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC Early Clinical Studies Group. Ann Oncol 1999;10:119-122.
-
(1999)
Ann. Oncol.
, vol.10
, pp. 119-122
-
-
Schöffski, P.1
Wanders, J.2
Catimel, G.3
-
13
-
-
7144263711
-
Clinical phase II evaluation of paclitaxel in combination with cisplatin in metastatic or recurrent squamous cell carcinoma of the head and neck
-
Thodtmann F, Theiss F, Kemmerich M, et al. Clinical phase II evaluation of paclitaxel in combination with cisplatin in metastatic or recurrent squamous cell carcinoma of the head and neck. Ann Oncol 1998;9:335-337.
-
(1998)
Ann. Oncol.
, vol.9
, pp. 335-337
-
-
Thodtmann, F.1
Theiss, F.2
Kemmerich, M.3
-
14
-
-
0000702241
-
Criteria for the evaluation of the clinical effects of solid cancer chemotherapy
-
Koyama Y, Saito T. Criteria for the evaluation of the clinical effects of solid cancer chemotherapy. J Jpn Soc Cancer Ther 1993; 28:101.
-
(1993)
J. Jpn. Soc. Cancer Ther.
, vol.28
, pp. 101
-
-
Koyama, Y.1
Saito, T.2
-
15
-
-
0023899654
-
Prospective randomized trial of high-dose cisplatin and fluorouracil infusion with or without sodium diethyldithiocarbamate in recurrent and/or metastatic squamous cell carcinoma of the head and neck
-
Paredes J, Hong WK, Felder TB, et al. Prospective randomized trial of high-dose cisplatin and fluorouracil infusion with or without sodium diethyldithiocarbamate in recurrent and/or metastatic squamous cell carcinoma of the head and neck. J Clin Oncol 1998;6:955-962.
-
(1998)
J. Clin. Oncol.
, vol.6
, pp. 955-962
-
-
Paredes, J.1
Hong, W.K.2
Felder, T.B.3
-
16
-
-
0026645077
-
Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: A Southwest Oncology Group study
-
Forastiere AA, Metch B, Schuller DE, et al. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study. J Clin Oncol 1992;10:1245-1251.
-
(1992)
J. Clin. Oncol.
, vol.10
, pp. 1245-1251
-
-
Forastiere, A.A.1
Metch, B.2
Schuller, D.E.3
-
17
-
-
0026569931
-
A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck
-
Jacobs C, Lyman G, Velez-Garcia E, et al. A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J Clin Oncol 1992;10:257-263.
-
(1992)
J. Clin. Oncol.
, vol.10
, pp. 257-263
-
-
Jacobs, C.1
Lyman, G.2
Velez-Garcia, E.3
-
18
-
-
0028359951
-
Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck. A phase III study of the EORTC Head and Neck Cancer Cooperative Group
-
Clavel M, Vermorken JB, Congnetti F, et al. Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck. A phase III study of the EORTC Head and Neck Cancer Cooperative Group. Ann Oncol 1994;5:521-526.
-
(1994)
Ann. Oncol.
, vol.5
, pp. 521-526
-
-
Clavel, M.1
Vermorken, J.B.2
Congnetti, F.3
-
19
-
-
6844236387
-
Phase III trial of modulation of cisplatin/fluorouracil chemotherapy by interferon alfa-2b in patients with recurrent or metastatic head and neck cancer
-
Head and Neck Interferon Cooperative Study Group
-
Schrijvers D, Johnson J, Jiminez U, et al. Phase III trial of modulation of cisplatin/fluorouracil chemotherapy by interferon alfa-2b in patients with recurrent or metastatic head and neck cancer. Head and Neck Interferon Cooperative Study Group. J Clin Oncol 1998;16:1054-1059.
-
(1998)
J. Clin. Oncol.
, vol.16
, pp. 1054-1059
-
-
Schrijvers, D.1
Johnson, J.2
Jiminez, U.3
-
20
-
-
0008502902
-
Clinical results of docetaxel (D) and 5-fluorouracil (5FU) in metastatic/recurrent squamous cell carcinoma of the head and neck (SCCHN)
-
Tubiana-Mathieu N, Cupissol D, Calais G, et al. Clinical results of docetaxel (D) and 5-fluorouracil (5FU) in metastatic/recurrent squamous cell carcinoma of the head and neck (SCCHN). Eur J Cancer 1999;35:S162.
-
(1999)
Eur. J. Cancer
, vol.35
-
-
Tubiana-Mathieu, N.1
Cupissol, D.2
Calais, G.3
-
21
-
-
0032214045
-
Recurrent squamous-cell lung cancer treated with bronchial-arterial infusion of docetaxel. Case report
-
Oura S, Sakurai T, Yoshimura G, et al. Recurrent squamous-cell lung cancer treated with bronchial-arterial infusion of docetaxel. Case report. Gan To Kagaku Ryoho 1998;25:2109-2113.
-
(1998)
Gan To Kagaku Ryoho
, vol.25
, pp. 2109-2113
-
-
Oura, S.1
Sakurai, T.2
Yoshimura, G.3
-
22
-
-
0033209087
-
A case of multiple liver metastases from breast cancer successfully treated with intra-arterial administration of docetaxel
-
Maeda Y, Nishida M, Takao T, et al. A case of multiple liver metastases from breast cancer successfully treated with intra-arterial administration of docetaxel. Gan To Kagaku Ryoho 1999; 26:1051-1054.
-
(1999)
Gan To Kagaku Ryoho
, vol.26
, pp. 1051-1054
-
-
Maeda, Y.1
Nishida, M.2
Takao, T.3
-
23
-
-
0035889882
-
Intraarterial chemotherapy with polyoxyethylated Castor oil free paclitaxel, incorporated in albumin nanoparticles (ABI-007)
-
Damascelli B, Cantu G, Mattavelli F, et al. Intraarterial chemotherapy with polyoxyethylated Castor oil free paclitaxel, incorporated in albumin nanoparticles (ABI-007). Cancer 2001; 92:2592-2602.
-
(2001)
Cancer
, vol.92
, pp. 2592-2602
-
-
Damascelli, B.1
Cantu, G.2
Mattavelli, F.3
-
24
-
-
0008502901
-
A phase II study of combined chemotherapy with docetaxel, cisplatin and 5-fluorouracil (5-FU) in patients with advanced squamous cell carcinoma of the head and neck (SCCHN) and nasopharyngeal carcinoma (NC)
-
[abstract] abst:1436
-
Janinis J, Papadakou M, Panagos G, et al. A phase II study of combined chemotherapy with docetaxel, cisplatin and 5-fluorouracil (5-FU) in patients with advanced squamous cell carcinoma of the head and neck (SCCHN) and nasopharyngeal carcinoma (NC) [abstract]. Proc Am Soc Clin Oncol 1997;16:402A abst:1436.
-
(1997)
Proc. Am. Soc. Clin. Oncol.
, vol.16
-
-
Janinis, J.1
Papadakou, M.2
Panagos, G.3
-
25
-
-
0033452294
-
Paclitaxel, cisplatin, and 5-fluorouracil for patients with advanced or recurrent squamous cell carcinoma of the head and neck
-
Hussain M, Gadgeel S, Kucuk O, et al. Paclitaxel, cisplatin, and 5-fluorouracil for patients with advanced or recurrent squamous cell carcinoma of the head and neck. Cancer 1999;86:2364-2369.
-
(1999)
Cancer
, vol.86
, pp. 2364-2369
-
-
Hussain, M.1
Gadgeel, S.2
Kucuk, O.3
|